Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Proinflammatory cytokines.

Dinarello CA.

Chest. 2000 Aug;118(2):503-8. Review.

PMID:
10936147
2.

Anti-cytokine therapies in response to systemic infection.

Dinarello CA.

J Investig Dermatol Symp Proc. 2001 Dec;6(3):244-50. Review.

3.

Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.

Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM.

Am J Respir Crit Care Med. 1997 Nov;156(5):1515-22.

PMID:
9372669
4.
5.
6.

Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.

Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P.

Am J Respir Crit Care Med. 1999 Feb;159(2):487-94.

PMID:
9927362
7.

The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators.

Marik PE, Zaloga GP; NORASEPT II Study Investigators. North American Sepsis Trial II.

J Am Geriatr Soc. 2001 Jan;49(1):5-9.

PMID:
11207836
8.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, HeinegÄrd D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

9.

Perspective of cytokine regulation for periodontal treatment: fibroblast biology.

Takashiba S, Naruishi K, Murayama Y.

J Periodontol. 2003 Jan;74(1):103-10. Review.

PMID:
12593604
11.

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.

J Bone Miner Res. 2001 Jun;16(6):1004-14.

12.

Anti-inflammatory cytokines.

Opal SM, DePalo VA.

Chest. 2000 Apr;117(4):1162-72. Review.

PMID:
10767254
13.

The mode of action of cytokine inhibitors.

Arend WP.

J Rheumatol Suppl. 2002 Sep;65:16-21. Review.

PMID:
12236617
14.

Biology of proinflammatory cytokines and their antagonists.

Moldawer LL.

Crit Care Med. 1994 Jul;22(7):S3-7. Review.

PMID:
8026189
16.
17.

Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.

Arthritis Rheum. 2004 Jan;50(1):277-90.

18.

[Contribution of cytokines to inflammatory mechanisms].

Cavaillon JM.

Pathol Biol (Paris). 1993 Oct;41(8 Pt 2):799-811. Review. French.

PMID:
7508593
19.
20.

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN.

J Immunol. 1999 Aug 1;163(3):1521-8.

Supplemental Content

Support Center